The volume of the target segment of the Russian pharmaceutical market in the 1st half of 2017 reached a value of 30 billion rubles, and the volume of 0.07 billion packages. The natural consumption in this segment and its value in rubles are growing noticeably, stimulated by the government’s active measures both with regard to vaccination of the population within the National Schedule of Preventive Vaccination (NSPV) and to treating socially significant diseases such as HIV and hepatitis.
The volume of the target segment of the Russian pharmaceutical market in the 1st half of 2017 reached a value of 30 billion rubles, and the volume of 0.07 billion packages. The natural consumption in this segment and its value in rubles are growing noticeably, stimulated by the government’s active measures both with regard to vaccination of the population within the National Schedule of Preventive Vaccination (NSPV) and to treating socially significant diseases such as HIV and hepatitis.
The reproduction of materials is allowed only if the limitations established by the Rightholder are observed, with mention of the author of the materials used and the reference to ALPHARM LLC as a source, with a mandatory hyperlink to www.alpharm.ru website.